Creative Peptides
Saralasin ([Sar1], [Ala8]-Ang II) is a partial agonist of angiotensin II receptors, though it is commonly mistaken as a competitive antagonist.
More Information
Supplier Page
Creative Peptides
This peptide from the Spike (S) protein of SARS-CoV is a naturally processed epitope shown to induce specific CTLs. The peptide epitope was validated in binding assay to HLA-A2 of T2 cell line. It also induced specific CD8+ T-cell responses against SARS-CoV. This peptide sequence is also seen within the spike glycoprotein of SARS-CoV2.
More Information
Supplier Page
Creative Peptides
This peptide corresponds to HBcAg-derived H-2b-restricted peptide, used as a negative control in HLA-A binding studies.
More Information
Supplier Page
Creative Peptides
This peptide corresponds to residues 411-420 of the spike protein of SARS-CoV and identified as a positive control for HLA binding studies.
More Information
Supplier Page
Creative Peptides
The SARS-CoV T-cell peptide antigens set contains 5 peptides corresponding to SARS-CoV spike protein sequence. The sequences have been tested for HLA binding with SARS-CoV protein and includes a positive and a negative control. CV1, CV2 and CV3 sequences are also seen within the spike glycoprotein of SARS-CoV2. The peptide sequences are offered in net […]
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 319-335 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 319-335 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 336-347 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 336-347 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 348-357 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 348-357 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 352-365 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 352-365 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 371-394 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 371-394 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
